Hereditary cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically and radiologically diagnosed patients with cardiomyopathy and two or more relatives in the family, including the proband, have been diagnosed as patients with cardiomyopathy. 2. Patients with cardiomyopathy were included in the following categories: hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, restrictive cardiomyopathy (RCA), left ventricular insufficiency (LVNC), cardiac amyloidosis, Danon's disease, Fabre's disease and their first-degree relatives. 3. Age: 0-90 years old.
Exclusion criteria
Exclusion criteria: 1. Patients refused to participate or were unable to complete the interview
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac magnetic resonance;Echocardiography;Second generation sequencing;Single cell sequencing;Family history;Genealogy chart;Clinical outcomes and outcomes (Hospital readmission due to heart failure, ICD implantation, medical chemical ablation or surgical Morrow myocardial resection, thromboembolism, pacemaker discharge or syncope recovery after resuscitation, heart transplant, death, cardiovasculary-related death); | — |
Secondary
| Measure | Time frame |
|---|---|
| Baseline data (Demographic data, physical examination, cardiac function Rating (NYHA),6-minute walking distance);Routine examination (12-lead ECG, blood routine, biochemistry, BNP);Medication status (current medication); | — |
Countries
China
Contacts
West China Hospital of Sichuan University